Parathyroid hormone (PTH) and calcitriol (1,25(OH)2D3) are key participants in the maintenance of calcium homeostasis in the body. Previous work has demonstrated that 1,25(OH)2D3, acting through its nuclear receptor (VDR), can directly suppress transcription of the PTH gene and DNA sequences that mediate this action have been identified. The broad objective of the proposed study is to elucidate the molecular basis for the effects of the steroid-receptor complex on suppressing PTH gene transcription. The hypothesis to be tested is that the transcriptional potential of the VDR complex is intrinsically coupled to the DNA sequence of the specific binding site. In this model, the DNA binding site acts as an allosteric effector to modulate the conformation of the VDR complex and thereby coordinate the ability of specific factors to associate with this complex to produce the desired transcriptional response. The proposed research will concentrate on a DNA sequence from the avian PTH (cPTH) gene previously characterized by the PI.
The specific aims of the proposed study include to 1) examine conformational changes that occur in the receptor binding to this negative sequence versus other DNA sequences known to elicit positive transcriptional responses to 1,25(OH)2D3 and 2) identify proteins that interact with the VDR complex as it drives expression from the cPTH response element and characterize their capacity to mediate repression of gene transcription by the vitamin in biochemical assays. Conformational changes in receptor structure will be monitored by protease mapping experiments that contrast VDR complexes bound to repressor and enhancer sequences. DNA-bending and phasing array analyses will also be conducted to determine if complex binding to these sequences results in an altered ability to bend DNA or in the orientation of the DNA bend. Parallel studies will identify and characterize protein factors that associate with an intact VDR complex as it drives expression from the cPTH DNA element in a yeast one-hybrid screen. Cloned proteins identified from this screen will be analyzed for their ability to mediate interactions with both negative and positive DNA response elements in transient transfection studies, pull-down assays, DNA affinity chromatography experiments and electrophoretic mobility shift assays. Investigation of the factors involved in vitamin D-dependent repression of PTH gene transcription will make significant contributions to our overall understanding of the less well-studied area of negative gene transcription by nuclear proteins. Moreover, it will provide new opportunities for investigating the underlying causes to the resistance to 1,25(OH)2D3 observed in patients with secondary hyperparathyroidism associated with impaired renal function, with the possibility of devising treatment modalities that focus on the factors identified in this study.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK054276-01A1
Application #
2904605
Study Section
General Medicine B Study Section (GMB)
Program Officer
Margolis, Ronald N
Project Start
1999-08-01
Project End
2003-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
832127323
City
Lexington
State
KY
Country
United States
Zip Code
40506
Alimov, Alexander P; Park-Sarge, Ok-Kyong; Sarge, Kevin D et al. (2005) Transactivation of the parathyroid hormone promoter by specificity proteins and the nuclear factor Y complex. Endocrinology 146:3409-16
Alimov, Alexander P; Langub, M Chris; Malluche, Hartmut H et al. (2004) Contrasting mammalian parathyroid hormone (PTH) promoters: nuclear factor-Y binds to a deoxyribonucleic acid element unique to the human PTH promoter and acts as a transcriptional enhancer. Endocrinology 145:2713-20
Koszewski, Nicholas J; Alimov, Alexander P; Park-Sarge, Ok-Kyong et al. (2004) Suppression of the human parathyroid hormone promoter by vitamin D involves displacement of NF-Y binding to the vitamin D response element. J Biol Chem 279:42431-7
Koszewski, Nicholas J; Rowan, Anne (2003) Heterodimer requirement for gene regulation by Vitamin D in variant OK cells. Steroids 68:307-14
Alimov, Alexander P; Langub, M Chris; Malluche, Hartmut H et al. (2003) Sp3/Sp1 in the parathyroid gland: identification of an Sp1 deoxyribonucleic acid element in the parathyroid hormone promoter. Endocrinology 144:3138-47
Malluche, Hartmut H; Monier-Faugere, Marie-Claude; Koszewski, Nick J (2002) Use and indication of vitamin D and vitamin D analogues in patients with renal bone disease. Nephrol Dial Transplant 17 Suppl 10:6-9
Koszewski, N J; Kiessling, S; Malluche, H H (2001) Isolation of genomic DNA sequences that bind vitamin D receptor complexes. Biochem Biophys Res Commun 283:188-94
Langub, M C; Reinhardt, T A; Horst, R L et al. (2000) Characterization of vitamin D receptor immunoreactivity in human bone cells. Bone 27:383-7
Koszewski, N J; Malluche, H H; Russell, J (2000) Vitamin D receptor interactions with positive and negative DNA response elements: an interference footprint comparison. J Steroid Biochem Mol Biol 72:125-32